Research in the Kompella lab is currently focused on nanotechnology as it pertains to drug and gene delivery via ocular, nasal, and pulmonary routes of administration. The research group utilizes supercritical fluid technology for the preparation of polymeric nanoparticles, nanoporous particles, microparticles, and soluble complexes used as novel therapeutic agents for the treatment of diabetic retinopathy, age-related macular degeneration, corneal angiogenesis, and cancers.
To learn more about the Kompella Lab including information on Dr. Kompella, publications, patents, opportunities, staff and equipment.
Information about Dr. Uday Kompella.
Publications by Dr. Kompella and the members of the Kompella Lab.
Patents by Dr. Kompella and associated research and lab members.
Members of the Kompella Research Lab.
Opportunities available for working in the Kompella Lab.
A list of the primary equipment availble for researchers in the Kompella Lab.
Events being held by or in association with the Kompella Lab